Select Your Language

Notifications

webdunia
webdunia
webdunia
मंगलवार, 15 अक्टूबर 2024
webdunia
Advertiesment

WHO releases its 2018 Blueprint list of priority diseases

WHO releases its 2018 Blueprint list of priority diseases
, Wednesday, 14 February 2018 (11:01 IST)
Kolkata: The World Health organization ( WHO) releases its 2018 list of priority pathogens that have the potential to cause a public health emergency and which have no, or insufficient, countermeasures.WHO calls on the medical community to unite in greater R&D efforts for these 8 diseases to develop treatments and vaccines to help control outbreaks.For the purposes of the R&D Blueprint, WHO has developed a special tool for determining which diseases and pathogens to prioritize for research and development in public health emergency contexts.

This tool seeks to identify those diseases that pose a public health risk because of their epidemic potential and for which there are no, or insufficient, countermeasures. The diseases identified through this process are the focus of the work of R& D Blueprint. This is not an exhaustive list, nor does it indicate the most likely causes of the next epidemic.The first list of prioritized diseases was released in December 2015.Using a published prioritization methodology, the list was first reviewed in January 2017.

The second annual review occurred February 6-7 last. Experts consider that given their potential to cause a public health emergency and the absence of efficacious drugs and/or vaccines, there is an urgent need for accelerated research and development for: Crimean-Congo haemorrhagic fever (CCHF), Ebola virus disease and Marburg virus disease, Lassa fever, Middle East respiratory syndrome coronavirus (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS), Nipah and henipaviral diseases, Rift Valley fever (RVF), Zika and Disease X.

Disease X represents the knowledge that a serious international epidemic could be caused by a pathogen currently unknown to cause human disease, and so the R&D Blueprint explicitly seeks to enable cross-cutting R&D preparedness that is also relevant for an unknown “Disease X” as far as possible. (UNI)

Share this Story:

Follow Webdunia english

Next Article

A strong doctor-patient relationship can cure Somatic symptom disorder